As the graphic below indicates, Portfolio A1 is currently trailing the benchmark SPX return by 1.5%, in large part due to the performance of PCCC, which is down 14.6% since it was purchased as part of the initial group of five holdings on 2/20. In spite of the poor performance, PCCC continues to be the top rated stock in our portfolio, though it is likely that without some near-term buying support, the RSI component of our stock ranker will force a sale in the next week or two.
It should be noted that the one stock from the original group of five that has been sold,
The equity curve, which is starting to look suspiciously like a duck to me, continues to show a high beta performance.
Current portfolio details are as follows: